SHARE:

Organizational Disclosure

Below is a breakdown of industry contribution towards the consolidated revenue of the Academy (American Academy of Neurology and American Academy of Neurology Institute). Industry includes for-profit entities that develop, produce, market, or distribute drugs, devices, services, or therapies used to diagnose, treat, monitor, manage, and alleviate health conditions (e.g., pharmaceutical and medical device/software manufacturers and other for-profit health services/product providers). Industry does not include non-profit entities, entities outside of the healthcare sector, or entities through which physicians provide clinical services directly to patients (e.g., hospitals, medical centers, publishers, foundations, recruiters, insurance providers).

2015

  • Total Industry Revenue: $7,543,824
  • Percentage of Total Academy Revenue: 17%
  • Educational Grants: $551,916
  • Sponsorship: $3,725,358
  • Exhibit Space: $2,516,550
  • Charitable Contributions:  
  • Industry Roundtable Membership Dues : $750,000

Total contribution by company in 2015 (Greater than $100K):

  • Novartis Pharmaceuticals
  • Biogen Idec
  • Sanofi Genzyme
  • TEVA Neuroscience, Inc.
  • Sunovion Pharmaceuticals Inc.
  • Allergan, Inc.
  • Lundbeck Inc.
  • Genentech
  • ACADIA Pharmaceuticals Inc.
  • FORUM Pharmaceuticals Inc.
  • Mallinckrodt Pharmaceuticals, Inc.
  • Medtronic, Inc.
  • Mylan
  • Eisai Inc.
  • Lilly USA, LLC
  • Supernus Pharmaceuticals, Inc.
  • Upsher-Smith

View the Principles Governing Academy Relationships with External Sources of Support.

View the Council of Medical Specialty Societies Code for Interactions with Companies.

Related Content

MEMBER LOG IN

Forgot password?

Advertisement
Advertisement